Related Experiment Video
Updated: Jul 30, 2025

07:18
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
7.0K
A Once-Thought Lipoma Turned Malignant Chondroid Syringoma
Noelle Provenzano1, Emerson T Trimble2, Kenneth Zeitzer3
1Internal Medicine, Einstein Medical Center Montgomery, East Norriton, USA.
Cureus
|May 16, 2023
Summary
Malignant chondroid syringoma (MCS) is a rare skin tumor. This case highlights diagnosing MCS in a lipoma, emphasizing the need for clear diagnostic and treatment guidelines for this rare cancer.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Chondroid syringoma is a rare benign skin appendageal tumor.
- Malignant chondroid syringoma (MCS) is exceptionally rare, with only 51 reported cases, primarily affecting women on the extremities or trunk.
- The rarity of MCS contributes to unclear diagnostic criteria and treatment protocols.
Observation:
- A 65-year-old woman presented with an elbow lipoma that increased in size and caused pain.
- Skin color changes were noted in the affected area.
- The patient's condition was re-evaluated based on evolving symptoms.
Findings:
- The tumor was diagnosed as Malignant Chondroid Syringoma (MCS) based on histological criteria.
- The diagnosis was made retrospectively on a lesion previously classified as a lipoma.
- This case represents a rare instance of MCS arising in a misdiagnosed condition.
Implications:
- This case underscores the diagnostic challenges posed by rare tumors like MCS.
- It highlights the importance of considering alternative diagnoses when lesions change or present with new symptoms.
- Further research is needed to establish definitive diagnostic criteria and treatment strategies for Malignant Chondroid Syringoma.
Related Concept Videos
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Skin Cancer
4.3K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.3K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

